| Literature DB >> 28771727 |
Yaoru Li1, Xiangjian Zhang1,2, Lili Cui1,2, Rong Chen1,2, Ye Zhang1, Cong Zhang1, Xingyuan Zhu1, Tingting He1, Zuyuan Shen1, Lipeng Dong1, Jingru Zhao1, Ya Wen1, Xiufen Zheng1, Pan Li1.
Abstract
Post-stroke angiogenesis facilitates neurovascular remodeling process and promotes neurological recovery. Proangiogenic effects of Salvianolic acids (Sals) have been reported in various ischemic disorders. However, the underlying mechanisms are still poorly understood. Previous studies of our laboratory have demonstrated that activating Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway is involved in the protection against cerebral ischemia/reperfusion injury. In this study, we investigated the impacts of Sals on angiogenesis and long-term neurological recovery after ischemic stroke as well as the potential mechanisms. Male mice subjected to permanent distal middle cerebral artery occlusion were administrated with Sals, 5-bromo-2'-deoxyuridine, and JAK2 inhibitor AG490 once daily from day 1 to day 14 after distal middle cerebral artery occlusion. Compared with the control group, Sals treatment significantly improved neurological recovery at day 14 and 28 after ischemic stroke. Sals enhanced post-stroke angiogenesis, pericytes and astrocytic endfeet covered ratio in the peri-infarct area. The JAK2/STAT3 signaling pathway was activated by Sals in the angiogenesis process, and inhibition of JAK2/STAT3 signaling blocked the effects of Sals on post-stroke angiogenesis and neurological recovery as well as abolished the mediation of proangiogenic factors. In summary, these data suggest that Sals administration enhances cerebral angiogenesis and promotes neurological recovery after ischemic stroke, mediated by the activation of JAK2/STAT3 signaling pathway.Entities:
Keywords: JAK2/STAT3; Salvianolic acids; angiogenesis; ischemic stroke; neurological recovery
Mesh:
Substances:
Year: 2017 PMID: 28771727 DOI: 10.1111/jnc.14140
Source DB: PubMed Journal: J Neurochem ISSN: 0022-3042 Impact factor: 5.372